NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,933
+2584.6%
320
+1500.0%
0.00%
Q2 2023$221
-77.8%
20
-73.0%
0.00%
Q1 2023$994
+302.4%
74
+270.0%
0.00%
Q4 2022$247200.0%0.00%
Q3 2022$0
-100.0%
20
-77.0%
0.00%
Q2 2022$1,000
-50.0%
87
-27.5%
0.00%
Q1 2022$2,000120
+500.0%
0.00%
Q4 2021$0200.0%0.00%
Q3 2021$0200.0%0.00%
Q2 2021$0
-100.0%
20
-85.2%
0.00%
Q1 2021$3,000135
+575.0%
0.00%
Q4 2020$0
-100.0%
20
-85.6%
0.00%
Q3 2020$6,000
-14.3%
1390.0%0.00%
Q2 2020$7,000
+600.0%
139
+595.0%
0.00%
Q1 2020$1,000
-50.0%
200.0%0.00%
Q4 2019$2,000
+100.0%
200.0%0.00%
Q3 2019$1,000
-93.3%
20
-89.2%
0.00%
Q2 2019$15,000
+275.0%
186
+353.7%
0.00%
Q1 2019$4,000
-77.8%
41
-77.5%
0.00%
Q4 2018$18,000
+260.0%
182
+451.5%
0.00%
Q3 2018$5,000
-50.0%
33
-72.5%
0.00%
Q2 2018$10,000
+100.0%
120
+37.9%
0.00%
Q1 2018$5,0000.0%870.0%0.00%
Q4 2017$5,0000.0%870.0%0.00%
Q3 2017$5,000870.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$9,514,0001.49%
CM Management, LLC 45,000$668,0000.50%
EULAV Asset Management 660,000$9,801,0000.26%
DLD Asset Management, LP 225,200$3,346,0000.24%
Virtus ETF Advisers LLC 21,387$318,0000.14%
GSA CAPITAL PARTNERS LLP 79,145$1,175,0000.12%
Hennion & Walsh Asset Management, Inc. 136,720$2,030,0000.11%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$2,507,0000.08%
Inspire Investing, LLC 31,868$473,0000.06%
DUALITY ADVISERS, LP 51,196$760,0000.06%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders